LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis

• Published in: Molecular cancer Vol. 19; no. 1; p. 85
• Main Authors: Liang, Yiran, Song, Xiaojin, Li, Yaming, Chen, Bing, Zhao, Wenjing, Wang, Lijuan, Zhang, Hanwen, Liu, Ying, Han, Dianwen, Zhang, Ning, Ma, Tingting, Wang, Yajie, Ye, Fangzhou, Luo, Dan, Li, Xiaoyan, Yang, Qifeng
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 08.05.2020; BioMed Central; BMC
• Subjects: Analysis; Animals; Antibodies; Apoptosis; Binding sites; Bioinformatics; Biomarkers, Tumor - genetics; Biomarkers, Tumor - metabolism; Breast cancer; Breast Neoplasms - genetics; Breast Neoplasms - metabolism; Breast Neoplasms - pathology; Cancer diagnosis; Cancer metastasis; Cell Proliferation; Chromatin; Cloning; Development and progression; Disease Progression; Exosomes; Female; Gene expression; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Hypoxia-inducible factors; Immunoprecipitation; Leukocyte migration; LncRNA BCRT1; Macrophages; Medical research; Metastases; Metastasis; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; MicroRNAs - genetics; miR-1303; Polarization; Polymerase chain reaction; Polypyrimidine Tract-Binding Protein - genetics; Polypyrimidine Tract-Binding Protein - metabolism; Prognosis; Progression; PTBP3; Ribonucleic acid; RNA; RNA, Long Noncoding - genetics; Software; Therapeutic applications; Tumor Cells, Cultured; Tumorigenesis; Xenograft Model Antitumor Assays; Japan; United States > US; China; Progression; miR-1303; Breast cancer; LncRNA BCRT1; PTBP3
• ISSN: 1476-4598; 1476-4598
• DOI: 10.1186/s12943-020-01206-5

Long noncoding RNAs (lncRNAs) play crucial roles in tumor progression and are aberrantly expressed in various cancers. However, the functional roles of lncRNAs in breast cancer remain largely unknown. Based on public databases and integrating bioinformatics analyses, the overexpression of lncRNA BCRT1 in breast cancer tissues was detected and further validated in a cohort of breast cancer tissues. The effects of lncRNA BCRT1 on proliferation, migration, invasion and macrophage polarization were determined by in vitro and in vivo experiments. Luciferase reporter assay and RNA immunoprecipitation (RIP) were carried out to reveal the interaction between lncRNA BCRT1, miR-1303, and PTBP3. Chromatin immunoprecipitation (ChIP) and RT-PCR were used to evaluate the regulatory effect of hypoxia-inducible factor-1α (HIF-1α) on lncRNA BCRT1. LncRNA BCRT1 was significantly upregulated in breast cancer tissues, which was correlated with poor prognosis in breast cancer patients. LncRNA BCRT1 knockdown remarkably suppressed tumor growth and metastasis in vitro and in vivo. Mechanistically, lncRNA BCRT1 could competitively bind with miR-1303 to prevent the degradation of its target gene PTBP3, which acts as a tumor-promoter in breast cancer. LncRNA BCRT1 overexpression could promote M2 polarization of macrophages, mediated by exosomes, which further accelerated breast cancer progression. Furthermore, lncRNA BCRT1 was upregulated in response to hypoxia, which was attributed to the binding of HIF-1α to HREs in the lncRNA BCRT1 promoter. Collectively, these results reveal a novel HIF-1α/lncRNA BCRT1/miR-1303/PTBP3 pathway for breast cancer progression and suggest that lncRNA BCRT1 might be a potential biomarker and therapeutic target for breast cancer.